Search

Gary Jackson

Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )

Most Active Art Unit
3731
Art Unit(s)
3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769
Total Applications
2094
Issued Applications
1632
Pending Applications
166
Abandoned Applications
295

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4682796 [patent_doc_number] => 20080249022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Antimicrobial Peptides Derived From Cap18' [patent_app_type] => utility [patent_app_number] => 11/658415 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11622 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249022.pdf [firstpage_image] =>[orig_patent_app_number] => 11658415 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/658415
Antimicrobial peptides derived from CAP18 Jul 25, 2005 Issued
Array ( [id] => 81169 [patent_doc_number] => 07745123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Cell cycle reporting cell line' [patent_app_type] => utility [patent_app_number] => 11/572516 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3187 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745123.pdf [firstpage_image] =>[orig_patent_app_number] => 11572516 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572516
Cell cycle reporting cell line Jul 21, 2005 Issued
Array ( [id] => 4507597 [patent_doc_number] => 07915218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Polypeptides for oligomeric assembly of antigens' [patent_app_type] => utility [patent_app_number] => 11/632385 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 15451 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915218.pdf [firstpage_image] =>[orig_patent_app_number] => 11632385 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/632385
Polypeptides for oligomeric assembly of antigens Jul 21, 2005 Issued
Array ( [id] => 5241727 [patent_doc_number] => 20070020219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Method for promoting hair growth' [patent_app_type] => utility [patent_app_number] => 11/187394 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3549 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020219.pdf [firstpage_image] =>[orig_patent_app_number] => 11187394 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/187394
Method for promoting hair growth Jul 20, 2005 Issued
Array ( [id] => 522145 [patent_doc_number] => 07186685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Compositions comprising gelatin-glycine and carotenoids' [patent_app_type] => utility [patent_app_number] => 11/177500 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4281 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186685.pdf [firstpage_image] =>[orig_patent_app_number] => 11177500 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177500
Compositions comprising gelatin-glycine and carotenoids Jul 10, 2005 Issued
Array ( [id] => 5807683 [patent_doc_number] => 20060094037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Proteins related to schizophrenia and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/170482 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19948 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094037.pdf [firstpage_image] =>[orig_patent_app_number] => 11170482 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/170482
Proteins related to schizophrenia and uses thereof Jun 27, 2005 Abandoned
Array ( [id] => 5771582 [patent_doc_number] => 20050267033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Multi-dose erythropoietin formulations' [patent_app_type] => utility [patent_app_number] => 11/167818 [patent_app_country] => US [patent_app_date] => 2005-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5593 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267033.pdf [firstpage_image] =>[orig_patent_app_number] => 11167818 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/167818
Multi-dose erythropoietin formulations Jun 26, 2005 Issued
Array ( [id] => 5710050 [patent_doc_number] => 20060051395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants' [patent_app_type] => utility [patent_app_number] => 11/152974 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15097 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051395.pdf [firstpage_image] =>[orig_patent_app_number] => 11152974 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/152974
IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants Jun 14, 2005 Issued
Array ( [id] => 6926452 [patent_doc_number] => 20050239708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis' [patent_app_type] => utility [patent_app_number] => 11/152468 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12746 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239708.pdf [firstpage_image] =>[orig_patent_app_number] => 11152468 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/152468
Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis Jun 13, 2005 Abandoned
Array ( [id] => 5769042 [patent_doc_number] => 20060019892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Conopeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/149757 [patent_app_country] => US [patent_app_date] => 2005-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19315 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019892.pdf [firstpage_image] =>[orig_patent_app_number] => 11149757 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/149757
Conopeptides and methods of use Jun 9, 2005 Abandoned
Array ( [id] => 925700 [patent_doc_number] => 07316998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-08 [patent_title] => 'Cerberus/Coco derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/140024 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 15209 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/316/07316998.pdf [firstpage_image] =>[orig_patent_app_number] => 11140024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/140024
Cerberus/Coco derivatives and uses thereof May 26, 2005 Issued
Array ( [id] => 567210 [patent_doc_number] => 07462476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Methods for large scale production of recombinant DNA-derived tPA or K2S molecules' [patent_app_type] => utility [patent_app_number] => 11/134385 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 8949 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462476.pdf [firstpage_image] =>[orig_patent_app_number] => 11134385 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/134385
Methods for large scale production of recombinant DNA-derived tPA or K2S molecules May 22, 2005 Issued
Array ( [id] => 151486 [patent_doc_number] => 07678544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'ADAM12, a novel marker for abnormal cell function' [patent_app_type] => utility [patent_app_number] => 11/131952 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 21481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678544.pdf [firstpage_image] =>[orig_patent_app_number] => 11131952 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/131952
ADAM12, a novel marker for abnormal cell function May 17, 2005 Issued
Array ( [id] => 4903992 [patent_doc_number] => 20080113405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Gene-Cassette For Enhancement Of Protein Production' [patent_app_type] => utility [patent_app_number] => 11/579419 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8006 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113405.pdf [firstpage_image] =>[orig_patent_app_number] => 11579419 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579419
Gene-Cassette For Enhancement Of Protein Production May 16, 2005 Abandoned
Array ( [id] => 5279178 [patent_doc_number] => 20090131310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Mucin3 egf-like domains' [patent_app_type] => utility [patent_app_number] => 11/596273 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9710 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131310.pdf [firstpage_image] =>[orig_patent_app_number] => 11596273 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596273
Mucin3 egf-like domains May 12, 2005 Abandoned
Array ( [id] => 8559932 [patent_doc_number] => 08333995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Protein microspheres having injectable properties at high concentrations' [patent_app_type] => utility [patent_app_number] => 11/127704 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 52 [patent_no_of_words] => 19379 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11127704 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127704
Protein microspheres having injectable properties at high concentrations May 11, 2005 Issued
Array ( [id] => 5715202 [patent_doc_number] => 20060078565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Nucleic acids and proteins from Group B Streptococcus' [patent_app_type] => utility [patent_app_number] => 11/123241 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 14350 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078565.pdf [firstpage_image] =>[orig_patent_app_number] => 11123241 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/123241
Nucleic acids and proteins from Group B Streptococcus May 5, 2005 Abandoned
Array ( [id] => 613005 [patent_doc_number] => 07148404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-12 [patent_title] => 'Antimicrobial polypeptides' [patent_app_type] => utility [patent_app_number] => 11/119581 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20621 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/148/07148404.pdf [firstpage_image] =>[orig_patent_app_number] => 11119581 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119581
Antimicrobial polypeptides May 1, 2005 Issued
Array ( [id] => 7057621 [patent_doc_number] => 20050278796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'FIAT nucleic acids and proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/118809 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26878 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20050278796.pdf [firstpage_image] =>[orig_patent_app_number] => 11118809 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/118809
FIAT nucleic acids and proteins and uses thereof Apr 28, 2005 Issued
Array ( [id] => 152197 [patent_doc_number] => 07678888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-16 [patent_title] => 'Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/593387 [patent_app_country] => US [patent_app_date] => 2005-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2908 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/678/07678888.pdf [firstpage_image] =>[orig_patent_app_number] => 10593387 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593387
Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof Apr 19, 2005 Issued
Menu